Duloxetine-Induced Subcortical Growth in a Patient With Major Depressive Disorder and Panic Disorder

被引：0
|
作者：
Lai, Chien-Han [1 ,2 ]
机构：
[1] Buddhist Tzu Chi Gen Hosp, Dept Psychiat, Taipei Branch, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan
来源：
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 2011年 / 23卷 / 02期
关键词：
ABNORMALITIES;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E42 / E43
页数：2
相关论文
共 50 条
  • [41] Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
    Schmaal, L.
    Veltman, D. J.
    van Erp, T. G. M.
    Saemann, P. G.
    Frodl, T.
    Jahanshad, N.
    Loehrer, E.
    Tiemeier, H.
    Hofman, A.
    Niessen, W. J.
    Vernooij, M. W.
    Ikram, M. A.
    Wittfeld, K.
    Grabe, H. J.
    Block, A.
    Hegenscheid, K.
    Voelzke, H.
    Hoehn, D.
    Czisch, M.
    Lagopoulos, J.
    Hatton, S. N.
    Hickie, I. B.
    Goya-Maldonado, R.
    Kraemer, B.
    Gruber, O.
    Couvy-Duchesne, B.
    Renteria, M. E.
    Strike, L. T.
    Mills, N. T.
    de Zubicaray, G. I.
    McMahon, K. L.
    Medland, S. E.
    Martin, N. G.
    Gillespie, N. A.
    Wright, M. J.
    Hall, G. B.
    MacQueen, G. M.
    Frey, E. M.
    Carballedo, A.
    van Velzen, L. S.
    van Tol, M. J.
    van der Wee, N. J.
    Veer, I. M.
    Walter, H.
    Schnell, K.
    Schramm, E.
    Normann, C.
    Schoepf, D.
    Konrad, C.
    Zurowski, B.
    MOLECULAR PSYCHIATRY, 2016, 21 (06) : 806 - 812
  • [42] Duloxetine-induced rapid eye movement sleep behavior disorder: a case report
    Lu Tan
    Junying Zhou
    Linghui Yang
    Rong Ren
    Ye Zhang
    Taomei Li
    Xiangdong Tang
    BMC Psychiatry, 17
  • [43] Serotonergic treatment of concomitant panic and major depressive disorder
    Targum, SD
    Muthu, P
    Marcus, R
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 596 - 596
  • [44] Duloxetine-induced rapid eye movement sleep behavior disorder: a case report
    Tan, Lu
    Zhou, Junying
    Yang, Linghui
    Ren, Rong
    Zhang, Ye
    Li, Taomei
    Tang, Xiangdong
    BMC PSYCHIATRY, 2017, 17
  • [45] Duloxetine and improvement of quality of life in patients with major depressive disorder
    Choustoulakis, I.
    Georgopoulou, A.
    Bornivelli, C.
    Karkazis, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S337 - S337
  • [46] Duloxetine vs placebo in the prevention of relapse of major depressive disorder
    Detke, M
    Gilaberte, I
    Perahia, D
    Wang, F
    McNamara, R
    Tran, P
    Miner, C
    Montgomery, SA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S261 - S262
  • [47] Duloxetine - A review of its use in the treatment of major depressive disorder
    Frampton, James E.
    Plosker, Greg L.
    CNS DRUGS, 2007, 21 (07) : 581 - 609
  • [48] BUDGET IMPACT ANALYSIS OF DULOXETINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Gwiosda, B.
    Rutkowski, J.
    Rys, P.
    Plisko, R.
    Wladysiuk, M.
    Cel, M.
    Mierzejewski, P.
    Bartminski, W.
    VALUE IN HEALTH, 2009, 12 (07) : A354 - A354
  • [49] FDA approves duloxetine for maintenance treatment of major depressive disorder
    Lanche, Michelisa
    CNS SPECTRUMS, 2008, 13 (01) : 23 - 23
  • [50] Duloxetine in the treatment of major depressive disorder: Comparisons of safety and efficacy
    Bailey, RK
    Mallinckrodt, CH
    Wohlreich, MM
    Watkin, JG
    Plewes, JM
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (03) : 437 - 447
12345